CORT
Corcept Therapeutics Incorporated
NASDAQ: CORT · HEALTHCARE · BIOTECHNOLOGY
$46.59
-0.06% today
Updated 2026-04-29
Market cap
$5.00B
P/E ratio
56.82
P/S ratio
6.57x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$29 – $91
Volume
1.8M
Corcept Therapeutics Incorporated (CORT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+19.1%
Last 4 quarters
Revenue YoY growth
+11.1%
Most recent quarter
EPS YoY growth
-23.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.5%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-13.6%
2026-02-18
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-18 | $0.20 | -21.3% | $39.63 | $34.24 | -13.6% |
| 2025-11-04 | $0.16 | +23.1% | $74.17 | $76.65 | +3.3% |
| 2025-07-28 | $0.29 | +55.6% | $68.29 | $68.20 | -0.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.25 | $0.20 | -21.3% | $202.13M | +11.1% |
| 2025-09-30 | $0.13 | $0.16 | +23.1% | $207.64M | +13.7% |
| 2025-06-30 | $0.19 | $0.29 | +55.6% | $194.43M | +18.7% |
| 2025-03-31 | $0.14 | $0.17 | +18.8% | $157.21M | +7.1% |
| 2024-12-31 | $0.42 | $0.26 | -38.6% | $181.89M | +34.3% |
| 2024-09-30 | $0.28 | $0.41 | +46.4% | $182.55M | +47.7% |
| 2024-06-30 | $0.23 | $0.32 | +39.1% | $163.80M | +39.1% |
| 2024-03-31 | $0.22 | $0.25 | +13.6% | $146.81M | — |
| 2023-12-31 | $0.26 | $0.28 | +7.7% | $135.41M | — |
| 2023-09-30 | $0.22 | $0.28 | +27.3% | $123.60M | — |
| 2023-06-30 | $0.15 | $0.25 | +66.7% | $117.72M | — |
Frequently asked questions
Has Corcept Therapeutics Incorporated beaten earnings estimates?
Corcept Therapeutics Incorporated has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +19.1% over the last 4 quarters.
How does CORT stock react to earnings?
CORT stock has moved an average of -3.5% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Corcept Therapeutics Incorporated's revenue growth rate?
Corcept Therapeutics Incorporated reported year-over-year revenue growth of +11.1% in its most recent quarter, with EPS growing -23.1% year-over-year.